ARXS NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Arxis, Inc. Class A Common Stock · Industrials · Aerospace & Defense

Open interactive chart View report data
Latest close 54.30 USD
28.1% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is - below the Trend Line and sits at 95.7% of its 52-week range. The latest completed week returned 28.1%, after a 20.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers. Options positioning is mixed with 41/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: price is close to its 52-week high; earnings are due in 10d.

Setup score 49 out of 100
Latest Close 54.30 USD 31 Jul 2026
1W Return 28.1% latest completed week
4W Return 20.8% short-term follow-through
12W Return 54.7% quarterly tape
Trend Breadth 0.0% 0 of 16 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Next-week expectancy is positive at 65.00% based on similar historical setup states.
  • Latest weekly return ranks in the strongest part of its sector group.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is negative, which weakens the current setup.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • 3 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 28.1% Latest completed week; four-week move 20.8%. Indicator stack 0/50 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 65.00% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Mixed 41/100 conviction; expected move 12.8%. News sentiment 54/100 33 relevant articles in the latest sentiment read. Event risk 10d Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is - below the Trend Line and sits at 95.7% of its 52-week range. The latest completed week returned 28.1%, after a 20.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1012-week average 0.05

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.10Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers

No recent accumulation markers. 3 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 20.8% over four weeks, 54.7% over 12 weeks, and - over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W28.1%
4W20.8%
12W54.7%
26W-
52W-
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.00Latest activity-pressure read.
Pressure change-Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 79% Model confidence 76%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength6/100Blend of value, momentum, and quality. Underlying universe rank 95; rank 1 is best.
Value4/100Relative valuation strength. Underlying universe rank 97; rank 1 is best.
Quality34/100Profitability and accounting quality. Underlying universe rank 67; rank 1 is best.
Momentum37/100Medium-term price momentum. Underlying universe rank 64; rank 1 is best.
Growth89/100Revenue and earnings growth. Underlying universe rank 12; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
10.9x
Market value relative to trailing revenue.
EV / EBITDA
63.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
1.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
47.3%
Gross profit retained from each unit of revenue.
Operating margin
7.1%
Operating profit retained from revenue.
Free-cash-flow margin
18.3%
Free cash flow generated from revenue.
Return on invested capital
1.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
115.5%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
194.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.1%
Cash dividends relative to market value.
Buyback yield
-0.1%
Net share repurchases relative to market value.
Shareholder yield
2.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
7.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

ARXS shows mixed options pressure with a 41/100 conviction score, put-call volume ratio of 1.35, expected move of 12.8%, and Sharemaestro trend signal inactive.

Conviction41/100
Expected move12.8%
Put/call volume1.35
Pressure-5
Speculation26
Volatility96
Trend agreement92
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment54/100

Weighted news tone is neutral across 33 relevant articles.

6 positive · 27 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings10dNext report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
Options expected move12.8%Nearest-chain priced movement where available.
52-week drawdown-1.7%Distance below the 52-week high.
13-week volatility11.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 155 weeks finished lower.
Best week+29.1%Week of 29 May.
Worst week-12.3%Week of 5 Jun.
Latest week+28.1%Week of 31 Jul.

Shape of recent returns

Strong gains3
Modest gains7
Flat weeks0
Modest losses2
Sharp losses3
Recent vol11.4%13-week weekly-return volatility.
Base vol11.1%52-week weekly-return volatility.
Up/down split10/5Count of positive and negative weeks in the 52-week window.
Average skew7.3% / -5.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape39/100

Trend, activity pressure, participation, and risk combine to a 39/100 tape read.

 Indicator analysis4/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.10; 3 reversal markers Next-Week ExpectancyPositive 65.00%

Next-week expectancy is positive with a 65.00% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors19/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 71; Small Cap Core rank 96 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options59/100

ARXS shows mixed options pressure with a 41/100 conviction score, put-call volume ratio of 1.35, expected move of 12.8%, and Sharemaestro trend signal inactive.

Mixed · Options-market disagreement · Expected move 12.8% Sentiment54/100

Weighted news tone is neutral across 33 relevant articles.

Carpenter Technology (CRS) Stock Looks Above Fair Value Despite Strong Earnings Insiders50/100

No recent insider transaction evidence is stored.

 Earnings10d

Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.

 Research flow1 items

1 recent research articles and 0 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202654.30 USD28.1%-40.70 USD0.00-5.8MOff
24 Jul 202642.40 USD1.4%-39.79 USD0.00-3.0MOff
17 Jul 202641.83 USD0.1%-39.60 USD0.00-4.1MOff
10 Jul 202641.79 USD-7.0%-39.43 USD0.00-3.1MOff
3 Jul 202644.95 USD1.4%-39.24 USD0.00-7.5MOff
26 Jun 202644.34 USD1.7%-38.72 USD0.00-7.7MOff
19 Jun 202643.61 USD6.4%-38.16 USD0.00-6.6MOff
12 Jun 202640.98 USD4.0%-37.55 USD0.00-3.8MOff
5 Jun 202639.41 USD-12.3%-37.12 USD0.00-4.5MOff
29 May 202644.93 USD29.1%-36.79 USD0.00-7.4MOff
22 May 202634.80 USD0.6%-35.44 USD0.00-2.2MOff
15 May 202634.59 USD-1.5%-35.56 USD0.00-5.4MOff
8 May 202635.10 USD-0.1%-35.81 USD0.00-2.8MOff
1 May 202635.13 USD0.4%-36.04 USD--4.3MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.